Chateal Eq
Product Images NDC 67296-1652

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Chateal Eq (NDC 67296-1652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Levo Ethi Fig1)

This is a chart showing information related to pregnancy risk in different groups of women. It mentions that the data is specific for non-pregnant, non-COC users, COC users, and postpartum women. It provides blood clot incidence per 10,000 women years for each group, with a specific note about pregnancy data based on actual duration. The available information includes ranges and specific numbers related to the risk of blood clots in these different categories of women.*

FDA Label Image

Figure (Levo Ethi Fig2)

This text provides information on various studies comparing the use of combined oral contraceptives (COC) to never using them. The studies include NICHD Women's Care Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses’ Health Study I, Oxford Family Planning Study, and Danish Sex Hormone Register Study. The results present odds ratios (OR), relative risks (RR), and hazard ratios (HR) with corresponding confidence intervals, evaluating the association between COC use and different health outcomes.*

FDA Label Image

Figure 3 (Levo Ethi Fig3)

This information outlines different methods of contraception and their effectiveness rates in preventing pregnancy. The text categorizes the efficacy of contraception methods based on the number of pregnancies expected per 100 women in one year. It includes options like implants, injections, intrauterine devices, sterilization, birth control pills, condoms, and natural family planning methods like avoiding sex during fertile days.*

FDA Label Image

Figure 4 (Levo Ethi Fig4)

The text provides information about storing a product at a temperature range of 20°C to 25°C (68°F to 77°F) as per USP Controlled Room Temperature guidelines. The text also includes the color descriptions "Orange" and "Green" along with the mention of days of the week (SUN, MON, TUE, WED, THU, FRI, SAT) and a reference to Figure A.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (28 Tablets Pouch))

This text appears to be a description of a pharmaceutical product named "Houspar Chateal EQ" which consists of Levonorgestrel and Ethinyl Estradiol Tablets USP in the strength of 0.15 mg/0.03 mg. The product comes in a blister card containing 21 orange tablets. The text also mentions other information such as NDC code, dosage instructions, and specific warnings. Overall, it seems to be detailing the packaging and contents of the medication.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (84 Tablets Carton))

Description: The text provides information on a pharmaceutical product called Chateal EQ, which is a combination of Levonorgestrel and Ethinyl Estradiol Tablets USP. It includes details about the dosage, packaging, and storage instructions for this oral contraceptive. The product is designed to prevent pregnancy but does not protect against sexually transmitted diseases. The text also mentions the manufacturer, Afaxys Pharma, and the intended use of the product.*

FDA Label Image

Chemical Structure1 (Levo Ethi Str1)

Levonorgestrel is a synthetic progestin used in hormonal contraceptives. It has a molecular formula of C21H28O2 and a molecular weight of 312.4 g/mol.*

FDA Label Image

Chemical Structure2 (Levo Ethi Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.